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Objectives: This study evaluated the biochemical prop-
erties of a local lime concentrate preparation called Aporo
and an ethanolic extract of seeds of Mucuna pruriens.
Methods: Six groups of male Wistar rats, each contain-
ing five rats, were selected. Diabetes was induced in all
rats, except the negative control group, by a single
intraperitoneal injection of 150 mg/kg Alloxan. The
induced rats, apart from the diabetic control group, were
treated by daily oral administration of 5 mg/kg Gliben-
clamide, 100 mg/kg of Aporo decoction, an ethanolic
extract ofM. pruriens seed, and a combination of both in
equal doses.
Results: After 15 days of treatment, the blood glucose
level of rats in the positive control group was found to be
significantly lower than that of the other rats. However,
Aporo extract exhibited a significantly higher ability to
reduce blood glucose than the standard hypoglycaemic
drug Glibenclamide. Aporo also increased high-density
lipoprotein (HDL) levels and decreased triglyceride
levels. The results showed that Aporo exhibited significant
antioxidant, antidiabetic and antidyslipidaemic proper-
ties when used alone rather than in combination with
Mucuna seed extracts.
Conclusion: This study endorses the folk use of Aporo in
the treatment of diabetes. However, further experimental
studies are required to complement the results of the
current study.his is an open access article under the CC BY-NC-ND license
16/j.jtumed.2016.02.004
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Diabetes mellitus has clearly achieved a leading position
among the causes of human mortality and morbidity in the
world today. This disease, according to statistics, affects
approximately 200 million people, which accounts for nearly
2.5% of the human population,1 and it is also a contributing
factor in 30% of all cardiovascular diseases.2,3 It is the most
common endocrine disorder associated with carbohydrate
metabolism,4 and it occurs as a result of abnormalities or
deficiencies in insulin secretion, insulin’s actions or both.
There is a growing belief that it is more of a body’s
response to a sedentary lifestyle than a putative disease.3
Diabetes is associated with complications from the increase
in blood glucose circulating through the body as well as
cardiovascular diseases due to the increase in triglyceride
and low-density lipoprotein (LDL) levels in the body. In
prolonged diabetes, some complications arise such as dia-
betic ketoacidosis, diabetic retinopathy, neuropathy and
nephropathy, which could lead to end-stage renal failure,
coma and sometimes death. Thus, it is desirable to provide
“natural” and cheap ways to prevent or manage diabetes and
to make such remedies readily available to the masses in a
traditional form. One such traditional approach is the use of
lime concentrate, popularly called Aporo in Nigeria, it is an
herbal concentrate. Because the use of Aporo is so wide-
spread, it deserves attention.
Aporo is a decoction traditionally made by locals by
boiling whole lime fruits (Citrus aurantifolia), including both
the rind and the lime juice, in large pots until most of the
water is evaporated and the solution is concentrated to
approximately half the original quantity, resulting in a very
dark slurry paste.5,6 Some other vendors prepare the
decoction using Citrus aurantium and Aframonium
melegueta. The resulting Aporo is regarded as a wonder-
cure for several ailments, including snake bites and scor-
pion stings, and it also possesses antimicrobial properties.6
Citrus fruit, from which Aporo is made, has been shown
to possess anti-diabetic and hypolipidaemic properties.7 It
has also been shown to have antioxidant properties
through its free radical scavenging properties by the
presence of phenolic compounds, anthocyannins and
vitamin C.
Mucuna pruriens (Linn), a bean-like leguminous plant, is
another potential cultural remedy for diabetes. Apart from
its common use as a treatment for infertility and as an
aphrodisiac,M. pruriens seeds are also known for their high
L-DOPA contents, which make them highly useful in tradi-
tional treatment of Parkinson’s disease. Studies carried out
by Majekodunmi et al.8 have shown that this seed possesses
anti-diabetic properties.This research was therefore aimed at evaluating the
antidiabetic, antidyslipidaemic and antioxidant effects
of Aporo and ethanolic extracts of seeds of M. pruriens
when administered singly and in combination with equal
dosages.Materials and Methods
M. pruriens and Aporo
Seeds ofM. pruriens were obtained from the International
Institute of Tropical Agriculture (IITA), Ibadan. The seeds
were washed, air-dried at approximately 25 C and subse-
quently reduced into a coarse powder using dry commercial
mill. Aporo was purchased from a manufacturer at Adodo
Palace, Egbe, Kogi state, Nigeria. It remained refrigerated at
2 Ce8 C until required for use.Preparation of seed extract
The seeds were washed thoroughly with distilled water,
air-dried, powdered using a commercial mill and soaked in
90% ethanol for 72 h. Milled seed (1 kg) was soaked in
2000 ml of ethanol and was stirred intermittently. It was then
sieved using a fine muslin cloth, after which the mixture was
filtered through Whatman filter paper. The extract was
concentrated using a rotary evaporator (Stuart, Germany)
and then dried in a water bath (Clifton) to remove the
remaining solvent. A golden brown, oily semi-viscous fluid
was obtained. The same milled seeds were extracted twice,
and an oily extract of 36.17 g was obtained with a yield of
3.617%. It was stored in an air tight container and refriger-
ated at 2 Ce8 C until required for use.Drugs and chemicals
Alloxan monohydrate was a product of Oxford Labo-
ratories Reagent, London. Finetest glucose strips were ob-
tained from Infopia Co., Ltd, Kyunggi-Do, Korea. A
glucose kit was obtained from Randox Diagnostics
(Crumlim, UK). HDL, total glycerides and total cholesterol
kits were products of Agape Diagnostics, Kerrala, India.
Glibenclamide tablets were products of Swiss Pharma
Nigeria Ltd and were obtained from the Landmark Uni-
versity Health Centre. All other reagents were of analytical
grade.Anti-diabetic studies
Experimental animals
Apparently healthy male Wistar rats weighing approxi-
mately 187.5 g were obtained from Covenant Farms, Olodo,
Ibadan, Oyo state. These animals were housed in standard
polypropylene cages and maintained under controlled room
temperature (25  5 C) with a 12-h light/dark cycle. The
cages were cleaned on a daily basis. The rats were acclima-
tized for two weeks before the commencement of the
experiment. The animals had access to a rat pellet diet and
clean water ad libitum.
Lime concentrate improved diabetic condition262Experimental induction of diabetes
Leaving aside five rats to serve as a negative control
group, diabetes was induced in overnight-fasted rats (12 h)
by intra-peritoneal injection of 150 mg/kg Alloxan dissolved
in 0.9% ice-cold saline immediately before use. The
same volume of 0.9% NaCl injectable solution was admin-
istered to the negative control rats. Seventy-two (72) hours
after Alloxan administration, blood samples were with-
drawn from the rat tails, and glucose levels were determined
using a glucometer to confirm the development of diabetes.
The rats exhibiting blood glucose levels above 250 mg/dl
were considered diabetic and were used for further
experimentation.Experimental design
The animals were sub-divided into six groups of five rats
each. The rats were grouped as follows:Group I: Negative Control rats received 1 ml of normal
saline daily for 15 days.
Group II: Positive Control rats underwent induction of
diabetes and received 1 ml of normal saline.
Group III: Diabetic Standard Control rats were
administered a standard reference drug,
Glibenclamide, dissolved in 1 ml normal
saline at a dose of 5 mg/kg body weight.
Group IV: Diabetic test rats were administered the Aporo
decoction dissolved in 1 ml normal saline at a
dose of 100 mg/kg body weight.
Group V: Diabetic test rats were administered the Aporo
decoction and M. pruriens ethanolic seed
extract mixed in equal dosages of 100 mg/kg
body weight and dissolved in 1 ml normal
saline.
Group VI: Diabetic test rats were administered
M. pruriens ethanolic seed extract at a dose
of 100 mg/kg body weight dissolved in 1 ml
normal saline.All administrations were performed orally using sterile
cannulas, and the daily treatments lasted for 15 days. The
selection of dosages was premised on a previous report by
Majekodunmi et al.8 that showed that doses in rats of up to
100 mg/kg for 12 weeks caused no significant adverse
effects. The rats were weighed before commencement of
the experiment, weekly during the experiment and
24 h before they were sacrificed. Blood was collected from
the tail by tail snip using a pair of surgical scissors on the
6th and 13th days of the experiment to determine blood
glucose concentrations; blood was collected in fluoride
oxalate sample bottles after the rats were sacrificed to
determine the final blood glucose concentration. Handling
of animals was consistent with international best practices
as approved by the Landmark University Ethics
Committee.Collection of blood samples
The rats were sacrificed under mild anaesthesia (diethyl
ether) 24 h after the last treatment. An aliquot (2 mL) of
blood was collected into fluoride oxalate sample bottles forthe analysis of blood glucose concentration. Another 5 mL of
the blood was collected in plain sample bottles and centri-
fuged at 4000g (Anke TDL-5000B, Shanghai, China) for
5 min to yield the serum, which was carefully aspirated with a
Pasteur pipette into sample bottles for the other biochemical
assays.Biochemical assays
Blood glucose levels after alloxan induction on the 6th
and 13th days of the experiment were estimated by the
enzymatic glucose oxidase method using a commercial auto-
coding glucometer (Finetest). Rat plasma glucose estima-
tion, serum cholesterol, triglycerides and HDL-cholesterol
were analysed using Randox assay kits (Crumlin, UK).
LDLecholesterol was estimated according to the method
described by Friedewald et al.9 Total serum protein was
determined using the biuret reaction as described by
Gornal et al.10 with slight modification: potassium iodide
was added to the biuret reagent to prevent the
precipitation of Cu2þ ions. The antioxidant activity of the
Aporo decoction and M. pruriens extracts were assayed by
estimating reduced glutathione (GSH) and lipid
peroxidation levels in rat serum. GSH was estimated by
the method of Ellman,11 while lipid peroxides were
estimated by the method of Varshney and Kale.12 Where
applicable, the absorbance was measured using a Jenway
UV/Vis Spectrophotometer (Staffordshire, UK).Statistical analysis
The results were expressed as the mean  standard de-
viation. The data were statistically analysed using one-way
analysis of variance (ANOVA) as the primary test, fol-
lowed by Tukey’s test for multiple comparisons using SPSS
software version 19 (IBM, 2010). Mean values at p < 0.05
was considered statistically significant.Results
Effect of treatments on blood glucose concentration
At day 6 of treatment, the positive (diabetic) control
group, as well as all other treated groups apart from the
Aporo-treated group, showed a significant (p < 0.001) in-
crease in blood glucose when compared with the negative
control group (Figure 1). The Aporo-treated group,
however, showed a significant (p < 0.05) decrease in blood
glucose relative to the positive (diabetic) control group. At
day 13 of treatment, there was a significant (p < 0.01)
increase in the blood glucose of the positive control group
when compared with the negative control group
(Figure 1). Additionally, a decrease in the blood glucose
level was recorded in all treated groups. After termination
of treatment, the blood glucose concentration was
significantly decreased in the groups treated with Aporo,
Glibenclamide and a combination of M. pruriens and
Aporo.
Figure 1: Effects of the various administrations on fasting blood glucose (mg/dl, days 6 and 13) and final plasma glucose (Day 15) levels of
normal and alloxan-induced diabetic rats. (Values are the mean  SD for 4e5 animals in each group. Values are statistically significant at
p < 0.05.)
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The positive (diabetic) control group showed a signifi-
cant (p < 0.001) decrease in serum HDL levels when
compared with the negative control group. Meanwhile,
treatment with M. pruriens as well as Aporo alone signifi-
cantly increased the HDL levels relative to the positiveFigure 2: Effects of the various administrations on serum lipid (mg/dl)
mean  SD for 4e5 animals in each group. Values are statistically sig(diabetic) control. The positive (diabetic) control group
showed an increase (p < 0.01) in serum LDL when
compared with the negative control (Figure 2). All treated
groups exhibited decreases in serum LDL levels.
Treatment with M. pruriens, Aporo or Glibenclamide did
not affect the level of rat serum total cholesterol relative
to the positive control. However, Aporo treatmentprofile of normal and alloxan-induced diabetic rats. (Values are the
nificant at p < 0.05.)
Figure 3: Effects of the various administrations on serum total protein of normal and alloxan-induced diabetic rats. (Values are the
mean  SD for 4e5 animals in each group. Values are statistically significant at p < 0.05.)
Lime concentrate improved diabetic condition264decreased (p < 0.05) the level of rat serum triglycerides
relative to the positive control group.Effect of treatment on serum total protein levels
The concentration of total protein in rats in the positive
(diabetic) control group was significantly lower when
compared to the negative control group (Figure 3). However,
treatment with Glibenclamide, Aporo and the combination
of M. pruriens and Aporo significantly elevated the proteinFigure 4: Effects of the various administrations on serum reduced glu
rats. (Values are the mean  SD for 4e5 animals in each group. Valulevel when compared with the positive control group
(Figure 3).Effect of treatment on reduced glutathione levels
Rats treated with Aporo alone had higher (p < 0.05) GSH
concentrations when compared to other groups (Figure 4).
The positive (diabetic) control group and the group treated
with a combination of M. pruriens and Aporo showed
lower GSH levels when compared to the negative control.tathione (mmol/ml) levels of normal and alloxan-induced diabetic
es are statistically significant at p < 0.05.)
Figure 5: Effects of the various administrations on serum lipid peroxidation levels (expressed as MDA units/mg protein) of normal and
alloxan-induced diabetic rats. (Values are the mean  SD for 4e5 animals in each group. Values are statistically significant at p < 0.05.)
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The positive (diabetic) control group showed significantly
higher levels of lipid peroxidation when compared with the
negative control group (Figure 5). Meanwhile, the treated
groups had significantly reduced lipid peroxidation relative
to the positive (diabetic) control group with the Aporo
treatment, which displayed the highest reduction in lipid
peroxidation (p < 0.001) when compared to the positive
control group.Discussion
A number of herbs have been demonstrated to be effective
in lowering blood glucose levels in alloxan-induced diabetic
animals.13 The two herbs tested in this study (Aporo and
M. pruriens tested individually and by co-administration)
have provided insight into the potentials of herbal medica-
tions. Although M. pruriens is reputed to possess anti-
diabetic properties, results from this study showed that the
Aporo decoction has an improved ability to decrease blood
glucose at a dose of 100 mg/kg. The results revealed that the
Aporo decoction is better than Glibenclamide, a standard
hypoglycaemic agent whose primary mechanism of hypo-
glycaemic action is increasing endogenous insulin secretion.14
The phytochemical analysis of the Aporo decoction car-
ried out by Adeleye et al.6 showed the presence of bioactive
compounds including tannin, flavonoid, alkaloids,
phylobatanin, anthocyanin, reducing sugar, saponin and
anthraquinone. Aporo is rich in anthocyannins.
Anthocyannins are powerful plant pigments that have been
characterized as some of the most powerful antioxidant
sources in lowering blood sugar by increasing endogenous
insulin secretion and conferring additional beneficial health
effects.15 Thus, the ability of Aporo to lower blood sugar
concentrations may be linked to the presence of this
compound. Contributing to the high antioxidant properties
is the richness of the antioxidant vitamin C.In lipid metabolism, Alloxan is known to induce hyper-
lipidaemia in diabetic animals by increasing free fatty acid
mobilization from the peripheral fat deposits.16 The results
obtained show no significant differences in the level of total
serum cholesterol. This indicates that although the
treatments influence the blood glucose, they have little
effect on the lipid status of diabetic animals. Thus the
treatments may not inhibit mobilization of free fatty acids;
the lack of inhibition may be due to the doses utilized or
the duration of the treatments in the study. However,
Aporo showed the ability to reduce atherogenic index by
significantly elevating serum HDL levels relative to the
diabetic control group. This suggests the potential of Aporo
to improve diabetes-related complications such as athero-
sclerosis. Aporo also caused a significant reduction in serum
triglyceride levels.
Much evidence has been recorded in the past few years
supporting the fact that diabetes is worsened by stress.1
Glutathione (GSH) is a tripeptide that contains a free thiol
group and is a major antioxidant in the human body. GSH
provides reducing equivalents for glutathione peroxidase
(GPx)-catalysed reduction of hydrogen peroxide and
lipohydroperoxides to water.17 The reduced level of GSH
in the diabetic group may suggest increased use due to
ensuing oxidative stress18; however, the significantly higher
levels of GSH in the diabetic rats treated with the Aporo
decoction is evidence that the GSH was preserved. This is
potentially due to decreased oxidative stress, which could
be attributed to the antioxidant properties of the Aporo
decoction. Further evidence of increased oxidative stress in
the diabetic state is based on increased lipid peroxidation
or reduced antioxidant reserves such as antioxidant
enzymes. Under normal conditions, the amount of lipid
peroxides in the body tissue serum is low; however, much
research on the effect of diabetes on the antioxidant state
of the body has shown that elevated levels of lipid
peroxides occur in the plasma of diabetic rats.19,20 This
effect is evidenced in the elevated lipid peroxide levels
Lime concentrate improved diabetic condition266observed in the diabetic control rats. However, treatment of
diabetic rats with either Glibenclamide, M. pruriens, Aporo
or the combination of M. pruriens and Aporo reduced lipid
peroxidation relative to the positive (diabetic) control
group. The group treated with Aporo decoction showed
much lower levels of lipid peroxidation relative to the
negative control, indicating the potential of Aporo to
reduce oxidative stress in addition to decreasing blood
glucose concentrations in the diabetic state.
Protein metabolism in the insulin-deficient state is cata-
bolic, so the body is continually breaking down body pro-
teins to compensate for required energy that is not being
provided by the metabolism of glucose.21 Thus, in the
diabetic state, wasting occurs, causing decreased total
protein levels. The results obtained from this study showed
that there was a significant decrease in the levels of total
protein of the diabetic rats; however, all treatments were
able to restore the total protein levels, as seen by the
significant elevation when compared with the diabetic and
negative control groups.
Co-administration of the M. pruriens extract with Aporo
had no added advantage in improving the lipid profile and
the antioxidant status of the diabetic animals. Aporo has
been implicated for antioxidant properties, most likely due to
the high level of vitamin C and anthocyanin contents.22 The
high antioxidant property of the Aporo decoction may be the
rationale of its wide usage in the management of various
diseases in Nigeria. This ability is especially important in
the management of diabetes and in the diminution of its
complications which are believed to be largely due to the
activities of free radicals. Additionally, according to Lachin
and Reza,15 plants having the ability to scavenge free
radicals in the body are supposed to have the ability to
restore the function of pancreatic tissues by increasing the
rate of insulin secretion.
Conclusion
Aporo possesses antidiabetic properties, which may be
linked to its antioxidant activity. Because oxidative stress is
associated with the diabetic condition, the use of a strong
antioxidant decoction such as Aporo could be relevant in
managing hyperglycaemia and diabetic complications. Our
data suggest that Aporo is better used alone than in combi-
nation with M. pruriens, as they are more effective individ-
ually than when combined. We recommend further
investigations to explore the use of Aporo as adjuvant ther-
apy in the management of diabetic condition.
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